25th February 2025

Market Exploration around Non-Compressible Haemorrhage

The Defence and Security Accelerator (DASA) is pleased to launch a new Market Exploration around Non-Compressible Haemorrhage (NCH).

Run on behalf of Research and Clinical Innovation (RCI) Research, Surgeon General’s Department, this Market Exploration is seeking to identify existing technologies and to understand who is doing work in this area and to uncover novel solutions for treating NCH at a combat casualty scene.

NCH refers to bleeding from anatomical structures that cannot be controlled, or only partially controlled, with application of external pressure, undertaken through an overlying tourniquet or direct manual pressure. Such bleeding is the chief cause of otherwise preventable battlefield death. NCH is highly lethal with a mortality rate of 85%.

If you work in this area or have an innovation that you think could be relevant to this area of research, please read the full Market Exploration document and submit a proposal!

The deadline for submissions in midday 12:00 (BST) on 15 April 2025.

Click here to learn more.